A CGM system provides continuous insight into glucose levels throughout the day and night. The device displays information about glucose direction and rate of change providing users additional information to help with their diabetes management. Studies have shown that CGM systems may help reduce your A1C and reduce your risk for hypoglycemia, whether you are on insulin injections or pump Therapy.
Highlights
The global Continuous Blood Glucose Monitoring Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Continuous Blood Glucose Monitoring Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Continuous Blood Glucose Monitoring Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Continuous Blood Glucose Monitoring Systems in Self/Home Care is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Continuous Blood Glucose Monitoring Systems include Abbott Laboratories, F. Hoffmann-La Roche, Lifescan, Ascensia Diabetes Care, Dexcom, Medtronic, Ypsomed, B. Braun Melsungen and Nipro, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Continuous Blood Glucose Monitoring Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Blood Glucose Monitoring Systems.
The Continuous Blood Glucose Monitoring Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Continuous Blood Glucose Monitoring Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Blood Glucose Monitoring Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Lifescan
Ascensia Diabetes Care
Dexcom
Medtronic
Ypsomed
B. Braun Melsungen
Nipro
Sanofi
Arkray
Prodigy Diabetes Care
Acon Laboratories
Nova Biomedical
Segment by Type
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Segment by Application
Self/Home Care
Hospital & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Blood Glucose Monitoring Systems companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Self-Monitoring Blood Glucose Systems
1.2.3 Continuous Glucose Monitoring Systems
1.3 Market by Application
1.3.1 Global Continuous Blood Glucose Monitoring Systems Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Self/Home Care
1.3.3 Hospital & Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Blood Glucose Monitoring Systems Market Perspective (2018-2029)
2.2 Continuous Blood Glucose Monitoring Systems Growth Trends by Region
2.2.1 Global Continuous Blood Glucose Monitoring Systems Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Continuous Blood Glucose Monitoring Systems Historic Market Size by Region (2018-2023)
2.2.3 Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Region (2024-2029)
2.3 Continuous Blood Glucose Monitoring Systems Market Dynamics
2.3.1 Continuous Blood Glucose Monitoring Systems Industry Trends
2.3.2 Continuous Blood Glucose Monitoring Systems Market Drivers
2.3.3 Continuous Blood Glucose Monitoring Systems Market Challenges
2.3.4 Continuous Blood Glucose Monitoring Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Continuous Blood Glucose Monitoring Systems Players by Revenue
3.1.1 Global Top Continuous Blood Glucose Monitoring Systems Players by Revenue (2018-2023)
3.1.2 Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Players (2018-2023)
3.2 Global Continuous Blood Glucose Monitoring Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Continuous Blood Glucose Monitoring Systems Revenue
3.4 Global Continuous Blood Glucose Monitoring Systems Market Concentration Ratio
3.4.1 Global Continuous Blood Glucose Monitoring Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Blood Glucose Monitoring Systems Revenue in 2022
3.5 Continuous Blood Glucose Monitoring Systems Key Players Head office and Area Served
3.6 Key Players Continuous Blood Glucose Monitoring Systems Product Solution and Service
3.7 Date of Enter into Continuous Blood Glucose Monitoring Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Blood Glucose Monitoring Systems Breakdown Data by Type
4.1 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Type (2018-2023)
4.2 Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Type (2024-2029)
5 Continuous Blood Glucose Monitoring Systems Breakdown Data by Application
5.1 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Application (2018-2023)
5.2 Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
6.2 North America Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2018-2023)
6.4 North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
7.2 Europe Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2018-2023)
7.4 Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
8.2 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2018-2023)
8.4 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
9.2 Latin America Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2018-2023)
9.4 Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
10.2 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2018-2023)
10.4 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Continuous Blood Glucose Monitoring Systems Introduction
11.1.4 Abbott Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Continuous Blood Glucose Monitoring Systems Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Lifescan
11.3.1 Lifescan Company Detail
11.3.2 Lifescan Business Overview
11.3.3 Lifescan Continuous Blood Glucose Monitoring Systems Introduction
11.3.4 Lifescan Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.3.5 Lifescan Recent Development
11.4 Ascensia Diabetes Care
11.4.1 Ascensia Diabetes Care Company Detail
11.4.2 Ascensia Diabetes Care Business Overview
11.4.3 Ascensia Diabetes Care Continuous Blood Glucose Monitoring Systems Introduction
11.4.4 Ascensia Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.4.5 Ascensia Diabetes Care Recent Development
11.5 Dexcom
11.5.1 Dexcom Company Detail
11.5.2 Dexcom Business Overview
11.5.3 Dexcom Continuous Blood Glucose Monitoring Systems Introduction
11.5.4 Dexcom Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.5.5 Dexcom Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Continuous Blood Glucose Monitoring Systems Introduction
11.6.4 Medtronic Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.6.5 Medtronic Recent Development
11.7 Ypsomed
11.7.1 Ypsomed Company Detail
11.7.2 Ypsomed Business Overview
11.7.3 Ypsomed Continuous Blood Glucose Monitoring Systems Introduction
11.7.4 Ypsomed Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.7.5 Ypsomed Recent Development
11.8 B. Braun Melsungen
11.8.1 B. Braun Melsungen Company Detail
11.8.2 B. Braun Melsungen Business Overview
11.8.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Systems Introduction
11.8.4 B. Braun Melsungen Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.8.5 B. Braun Melsungen Recent Development
11.9 Nipro
11.9.1 Nipro Company Detail
11.9.2 Nipro Business Overview
11.9.3 Nipro Continuous Blood Glucose Monitoring Systems Introduction
11.9.4 Nipro Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.9.5 Nipro Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Continuous Blood Glucose Monitoring Systems Introduction
11.10.4 Sanofi Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.10.5 Sanofi Recent Development
11.11 Arkray
11.11.1 Arkray Company Detail
11.11.2 Arkray Business Overview
11.11.3 Arkray Continuous Blood Glucose Monitoring Systems Introduction
11.11.4 Arkray Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.11.5 Arkray Recent Development
11.12 Prodigy Diabetes Care
11.12.1 Prodigy Diabetes Care Company Detail
11.12.2 Prodigy Diabetes Care Business Overview
11.12.3 Prodigy Diabetes Care Continuous Blood Glucose Monitoring Systems Introduction
11.12.4 Prodigy Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.12.5 Prodigy Diabetes Care Recent Development
11.13 Acon Laboratories
11.13.1 Acon Laboratories Company Detail
11.13.2 Acon Laboratories Business Overview
11.13.3 Acon Laboratories Continuous Blood Glucose Monitoring Systems Introduction
11.13.4 Acon Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.13.5 Acon Laboratories Recent Development
11.14 Nova Biomedical
11.14.1 Nova Biomedical Company Detail
11.14.2 Nova Biomedical Business Overview
11.14.3 Nova Biomedical Continuous Blood Glucose Monitoring Systems Introduction
11.14.4 Nova Biomedical Revenue in Continuous Blood Glucose Monitoring Systems Business (2018-2023)
11.14.5 Nova Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
F. Hoffmann-La Roche
Lifescan
Ascensia Diabetes Care
Dexcom
Medtronic
Ypsomed
B. Braun Melsungen
Nipro
Sanofi
Arkray
Prodigy Diabetes Care
Acon Laboratories
Nova Biomedical
听
听
*If Applicable.
